IRS Awards Array Firms $16M to Develop Next-Generation Tests

Companies developing array- or biochip-based molecular diagnostics received a shot in the arm earlier this month under the Internal Revenue Service's $1 billion Qualifying Therapeutic Discovery Project program.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.